Login
Toggle navigation
Videos
Categories
Trending
Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
I80 Gold CEO Euan Downey Discusses Market Trends and Company Strategy Amidst Industry Challenges
00:10:00
Midas Gold Highlights Idaho Gold Project at One-to-One Mining Investment Conference
00:10:00
Global Expansion and Hydrogen Innovation: A Conversation with HDF Energy's President | Damien Havard, CEO, Hydrogene De France SA.
00:10:00
Commvault CEO Sanjay Mirchandani discusses how his company has 'democratized' cloud security in a Fortt Knox Update.|Sanjay Mirchandani, has served as our President and Chief Executive Officer of Commvault
00:10:00
Vanguard CEO Tim Buckley: Keep Going Despite Market Chaos | Tim Buckley, CEO, Aeffe SpA
00:10:00
Navigating Market Ups and Downs: Mike Cintolo's Weekly Review | Mike Cintolo - market analyst and the editor of Cabot Market Letter
00:10:00
Unveiling eToro: A Decade of Financial Innovation | Yoni Assia , CEO, eToro.
00:10:00
Understanding Military History to Avoid Repeating Past Mistakes
00:10:00
DOKTA (Döktaş Foundry Trade and Industry Inc.) | Tevfik YAMANTÜRK - Chairman of Componenta Dokumculuk Ticaret ve Sanayi AS
00:10:00
Niklas Pålsson Discusses Cedergrenska's Year-End Report and Future Plans | Niklas Pålsson, Board Member, Cedergrenska AB.
00:10:00
One Year of GDPR: Insights from Hogan Lovells Experts | Miguel A. Zaldivar, Jr. - Chief Executive Officer of Hogan Lovells
00:10:00
Insight Partners has helped over 600 companies|George Mathew,Managing Director,Insight Partners